by GRAIL
GRAIL utilizes AI to analyze cell-free DNA (cfDNA) and identify methylation patterns in blood samples, allowing for the early detection of over 50 types of cancer before symptoms appear. Its machine learning models process massive genomic datasets to differentiate healthy DNA from cancerous DNA and pinpoint the cancer's likely tissue of origin.
Complete information about the vendor/provider of this AI application
1 considerations identified
Review recommended before use
These considerations are automatically identified based on publicly available information about the vendor and AI catalog data. Actual risks may vary based on your specific use case and implementation.
Legal, privacy, and compliance documentation
Get insights into risk by running assessments on this AI application.
Types of data commonly processed by this application
Discover EU-based alternatives for this AI application.
Track, assess, and govern your AI applications with Anove.
